Option Care Health (NASDAQ:OPCH) Reaches New 1-Year Low – Here’s Why

Option Care Health, Inc. (NASDAQ:OPCH) hit a new 52-week low during trading on Wednesday . The stock traded as low as $22.20 and last traded at $22.28, with a volume of 747109 shares trading hands. The stock had previously closed at $22.85.

Analysts Set New Price Targets

Several research analysts have weighed in on OPCH shares. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Price Performance

The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market cap of $3.78 billion, a P/E ratio of 18.65, a price-to-earnings-growth ratio of 2.30 and a beta of 1.32. The business has a 50-day simple moving average of $28.82 and a 200 day simple moving average of $29.44.

Insiders Place Their Bets

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. This represents a 69.02 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the stock in a transaction dated Friday, November 8th. The stock was bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

Several institutional investors and hedge funds have recently bought and sold shares of the company. UMB Bank n.a. lifted its position in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares in the last quarter. Blue Trust Inc. grew its position in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC bought a new stake in shares of Option Care Health during the 1st quarter valued at $85,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.